Trial Profile
A real world study comparing outcomes of Albiglutide and Liraglutide in patients with Type 2 Diabetes Mellitus in the United States
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Albiglutide (Primary) ; Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 25 May 2017 New trial record
- 24 May 2017 Results presented at the 22nd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research